← Leaderboards
Victor Krasnykh
Vectorlogics, Inc.
$4,054,909
Attributed
$4,054,909
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $641.7K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,054,909 · 8
By mechanism
R01$2,533,315 · 2
R21$817,300 · 2
R43$444,294 · 2
R03$160,000 · 1
R41$100,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsImageDesignTumorAffinitySpecificityMalignant NeoplasmsProteinsMolecularBaseNormal Tissue MorphologyCancer PatientGene TherapyLifeDiagnosticTissuesLigandsReceptor BindingModificationAdenovirusesGenesGene DeliveryCancer TherapyAdenovirus Vector
Grant awards (17)
Novel probes for near-infrared fluorescence imaging-guided oncologic surgery$80,000
R03 · FY2016 · EB · contact PI
New generation of radiotracers for PET imaging of molecular signatures of tumors$174,000
R21 · FY2015 · CA · contact PI
Novel probes for near-infrared fluorescence imaging-guided oncologic surgery$80,000
R03 · FY2015 · EB · contact PI
New generation of radiotracers for PET imaging of molecular signatures of tumors$208,800
R21 · FY2014 · CA · contact PI
Tumor-specific gene vectors for imaging and therapy of metastatic disease$197,500
R21 · FY2012 · EB · contact PI
Multi-serotype adenovirus vector system for targeted gene delivery to tumors$309,964
R01 · FY2011 · CA · contact PI
Tumor-specific gene vectors for imaging and therapy of metastatic disease$237,000
R21 · FY2011 · EB · contact PI
Multi-serotype adenovirus vector system for targeted gene delivery to tumors$319,550
R01 · FY2010 · CA · contact PI
Her2-targeted vectors for gene therapy of cancer$322,145
R01 · FY2009 · CA · contact PI
Multi-serotype adenovirus vector system for targeted gene delivery to tumors$319,550
R01 · FY2009 · CA · contact PI
Her2-targeted vectors for gene therapy of cancer$322,144
R01 · FY2008 · CA · contact PI
Her2-targeted vectors for gene therapy of cancer$300,602
R01 · FY2007 · CA · contact PI
Her2-targeted vectors for gene therapy of cancer$309,580
R01 · FY2006 · CA · contact PI
Her2-targeted vectors for gene therapy of cancer$329,780
R01 · FY2005 · CA
Tumor-Specific Replicative Adenoviruses$100,000
R43 · FY2002 · CA
Derivation of Dendritic Cell-Specific Adenovirus Vectors$100,000
R41 · FY2001 · CA
ADVANCED GENERATION VECTORS FOR CANCER GENE THERAPY$344,294
R43 · FY2000 · CA